Research progress on bariatric surgery for hyperuricemia.
Bariatric surgery
Gout
Hyperuricemia
Obesity
Serum uric acid
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
21 Aug 2024
21 Aug 2024
Historique:
received:
05
06
2024
accepted:
06
08
2024
medline:
22
8
2024
pubmed:
22
8
2024
entrez:
21
8
2024
Statut:
epublish
Résumé
Hyperuricemia is closely linked to obesity. As lifestyles and dietary patterns evolve, the prevalence of hyperuricemia has been on the rise. Bariatric surgery, an efficacious intervention for morbid obesity and its associated metabolic disorders, not only manages the weight of patients with severe obesity but also exerts beneficial therapeutic effects on hyperuricemia and gout. Moreover, it demonstrates substantial efficacy against other obesity-related metabolic conditions. However, the dramatic fluctuations in serum uric acid levels and acute gouty attacks in the immediate postoperative period are issues that should not be overlooked, and effective preventative strategies for some related adverse complications are still underexplored. This review discusses and reviews the advancements in the treatment of obese patients with hyperuricemia through bariatric surgery. By reviewing pertinent literature, it summarizes the short-term and long-term therapeutic outcomes of bariatric surgery for hyperuricemia, as well as common adverse reactions. Furthermore, by discussing preoperative and postoperative interventional measures and influential factors, this review aims to provide novel perspectives for the clinical management of hyperuricemia and offer insights for the prevention of related complications.
Identifiants
pubmed: 39169366
doi: 10.1186/s12893-024-02525-w
pii: 10.1186/s12893-024-02525-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
235Subventions
Organisme : National Natural Science Foundation of China
ID : 82370601
Informations de copyright
© 2024. The Author(s).
Références
Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors [J]. Nat Rev Rheumatol. 2020;16(7):380–90. https://doi.org/10.1038/s41584-020-0441-1
Maiuolo J, Oppedisano F, Gratteri S, et al. Regulation of uric acid metabolism and excretion [J]. Int J Cardiol. 2016;213:8–14. https://doi.org/10.1016/j.ijcard.2015.08.109
doi: 10.1016/j.ijcard.2015.08.109
pubmed: 26316329
Dalbeth N, Gosling AL, Gaffo A et al. Gout [J]. Lancet. 2021;397(10287):1843–55. https://doi.org/10.1016/s0140-6736(21)00569-9
Ny Fang L, Lv X, Lv et al. Multidisciplinary Expert Consensus on the diagnosis and treatment of Hyperuricemia-related diseases in China (2023 Edition) [J]. ZHONGGUO SHIYONG NEIKE ZAZHI. 2023;43(06):461–80. https://doi.org/10.19538/j.nk2023060106
The Lancet Diabetes E. Obesity in China: time to act [J]. Lancet Diabetes Endocrinol. 2021;9(7):407. https://doi.org/10.1016/s2213-8587(21)00150-9
Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and Cardiovascular diseases [J]. Circ Res. 2020;126(11):1477–500. https://doi.org/10.1161/circresaha.120.316101
Fritz J, Brozek W, Concin H et al. The Association of Excess Body Weight with risk of ESKD is mediated through insulin resistance, hypertension, and hyperuricemia [J]. J Am Soc Nephrol. 2022;33(7):1377–89. https://doi.org/10.1681/asn.2021091263
Sandoval DA, Patti ME. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia [J]. Nat Rev Endocrinol. 2023;19(3):164–76. https://doi.org/10.1038/s41574-022-00757-5
Acevedo-Fernández M, Porchia LM, Elguezabal-Rodelo RG et al. Concurrence of hyperinsulinemia and hyperuricemia significantly augmented all-cause mortality [J]. Nutr Metab Cardiovasc Dis. 2023;33(9):1725–32. https://doi.org/10.1016/j.numecd.2023.05.023
Li Z, Gao L, Zhong X et al. Association of Visceral Fat Area and Hyperuricemia in Non-Obese US Adults: A Cross-Sectional Study [J]. Nutrients. 2022;14(19). https://doi.org/10.3390/nu14193992
McCormick N, Yokose C, Lu N et al. Impact of adiposity on risk of female gout among those genetically predisposed: sex-specific prospective cohort study findings over > 32 years [J]. Ann Rheum Dis. 2022;81(4):556–63. https://doi.org/10.1136/annrheumdis-2021-221635
Ran Z, Xue X, Han L et al. Decrease in serum urate level is Associated with loss of visceral Fat in male gout patients [J]. Front Endocrinol (Lausanne). 2021;12:724822. https://doi.org/10.3389/fendo.2021.724822
Friedman AN, Kaplan LM, le Roux CW et al. Management of obesity in adults with CKD [J]. J Am Soc Nephrol. 2021;32(4):777–90. https://doi.org/10.1681/asn.2020101472
Zhu P, Herrington WG, Haynes R et al. Conventional and genetic evidence on the Association between Adiposity and CKD [J]. J Am Soc Nephrol. 2021;32(1):127–37. https://doi.org/10.1681/asn.2020050679
Yang Y, Xian W, Wu D et al. The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study [J]. Front Endocrinol (Lausanne). 2022;13:917056. https://doi.org/10.3389/fendo.2022.917056
Hong C, Zhang Q, Chen Y et al. Elevated uric acid mediates the effect of obesity on Hypertension Development: a Causal Mediation Analysis in a prospective longitudinal study [J]. Clin Epidemiol. 2022;14:463–73. https://doi.org/10.2147/clep.S363429
Manca C, Pintus S, Murru E et al. Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-α Activation in Obese Subjects Post Bariatric Surgery [J]. Nutrients. 2021;13(12). https://doi.org/10.3390/nu13124340
McCormick N, Rai SK, Lu N et al. Estimation of Primary Prevention of Gout in Men through Modification of Obesity and other Key Lifestyle factors [J]. JAMA Netw Open. 2020;3(11):e2027421. https://doi.org/10.1001/jamanetworkopen.2020.27421
Chang YH, Chiang YF, Chen HY et al. Anti-inflammatory and anti-hyperuricemic effects of Chrysin on a high fructose corn syrup-Induced Hyperuricemia Rat Model via the amelioration of Urate Transporters and Inhibition of NLRP3 Inflammasome Signaling pathway [J]. Antioxidants (Basel). 2021;10(4). https://doi.org/10.3390/antiox10040564
Strilchuk L, Fogacci F, Cicero AF. Safety and tolerability of available urate-lowering drugs: a critical review [J]. Expert Opin Drug Saf. 2019;18(4):261–71. https://doi.org/10.1080/14740338.2019.1594771
Zhang H, Fealy CE, Kirwan JP. Exercise training promotes a GDF15-associated reduction in fat mass in older adults with obesity [J]. Am J Physiol Endocrinol Metab. 2019;316(5):E829–36. https://doi.org/10.1152/ajpendo.00439.2018
Martin M, Beekley A, Kjorstad R et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis [J]. Surg Obes Relat Dis. 2010;6(1):8–15. https://doi.org/10.1016/j.soard.2009.07.003
Nguyen N, Champion JK, Ponce J et al. A review of unmet needs in obesity management [J]. Obes Surg. 2012;22(6):956–66. https://doi.org/10.1007/s11695-012-0634-z
Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus [J]. Ann Surg. 1995;222(3):339–52. https://doi.org/10.1097/00000658-199509000-00011
Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: Development of standards for patient safety and efficacy [J]. Metabolism. 2018;79:97–107. https://doi.org/10.1016/j.metabol.2017.12.010
Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine [J]. Ann Surg. 1954;140(3):439–48. https://doi.org/10.1097/00000658-195409000-00018
Mason EE, Ito C. Gastric bypass [J]. Ann Surg. 1969;170(3):329–39. https://doi.org/10.1097/00000658-196909010-00003
doi: 10.1097/00000658-196909010-00003
pubmed: 5804373
pmcid: 1387676
Wiggins T, Majid MS, Agrawal S. From the Knife to the Endoscope-a history of bariatric surgery [J]. Curr Obes Rep. 2020;9(3):315–25. https://doi.org/10.1007/s13679-020-00386-x
Wei Y, Li P, Zhang S. From surgery to endoscopy: the evolution of the bariatric discipline [J]. Chin Med J (Engl). 2022;135(20):2427–35. https://doi.org/10.1097/cm9.0000000000002409
Docherty NG, le Roux CW. Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus [J]. Nat Rev Nephrol. 2020;16(12):709–20. https://doi.org/10.1038/s41581-020-0323-4
Pareek M, Schauer PR, Kaplan LM et al. Metabolic surgery: weight loss, diabetes, and beyond [J]. J Am Coll Cardiol. 2018;71(6):670–87. https://doi.org/10.1016/j.jacc.2017.12.014
Ferraz-Bannitz R, Kashyap S, Patti ME. Bariatric Surgery: It’s Not Just Incretins! [J]. J Clin Endocrinol Metab. 2022;107(2):e883–5. https://doi.org/10.1210/clinem/dgab694
Maglio C, Peltonen M, Neovius M et al. Effects of bariatric surgery on gout incidence in the Swedish obese subjects study: a non-randomised, prospective, controlled intervention trial [J]. Ann Rheum Dis. 2017;76(4):688–93. https://doi.org/10.1136/annrheumdis-2016-209958
Vafa L, Amini M, Kamran H et al. The impact of obesity surgery on serum uric acid in people with severe obesity: a retrospective study [J]. Clin Nutr Res. 2023;12(1):21–8. https://doi.org/10.7762/cnr.2023.12.1.21
Hung KC, Ho CN, Chen IW et al. Impact of serum uric acid on renal function after bariatric surgery: a retrospective study [J]. Surg Obes Relat Dis. 2020;16(2):288–95. https://doi.org/10.1016/j.soard.2019.10.029
Lu J, Bai Z, Chen Y et al. Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis [J]. Rheumatology (Oxford). 2021;60(8):3628–34. https://doi.org/10.1093/rheumatology/keaa822
Oberbach A, Neuhaus J, Inge T et al. Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia [J]. Metabolism. 2014;63(2):242–9. https://doi.org/10.1016/j.metabol.2013.11.012
Antozzi P, Soto F, Arias F et al. Development of acute gouty attack in the morbidly obese population after bariatric surgery [J]. Obes Surg. 2005;15(3):405–7. https://doi.org/10.1381/0960892053576802
Li M, Liu Y, Zeng N et al. Alterations in the serum urate concentrations after bariatric surgery: a short-term prospective observational study [J]. Obes Surg. 2021;31(4):1688–95. https://doi.org/10.1007/s11695-020-05181-0
Katsogridaki G, Tzovaras G, Sioka E et al. Hyperuricemia and acute gout after laparoscopic sleeve gastrectomy [J]. Clin Obes. 2019;9(2):e12296. https://doi.org/10.1111/cob.12296
Kang EH, Lee EY, Lee YJ et al. Clinical features and risk factors of postsurgical gout [J]. Ann Rheum Dis. 2008;67(9):1271–5. https://doi.org/10.1136/ard.2007.078683
Yip K, Berman J. What is gout? [J]. Jama. 2021;326(24):2541. https://doi.org/10.1001/jama.2021.19770
Favero M, El-Hadi H, Belluzzi E et al. Infrapatellar fat pad features in osteoarthritis: a histopathological and molecular study [J]. Rheumatology (Oxford). 2017;56(10):1784–93. https://doi.org/10.1093/rheumatology/kex287
Hui W, Litherland GJ, Elias MS et al. Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases [J]. Ann Rheum Dis. 2012;71(3):455–62. https://doi.org/10.1136/annrheumdis-2011-200372
Berry KM, Neogi T, Baker JF et al. Obesity progression between young adulthood and midlife and incident arthritis: a retrospective cohort study of US adults [J]. Arthritis Care Res (Hoboken). 2021;73(3):318–27. https://doi.org/10.1002/acr.24252
Anderson IJ, Davis AM, Jan RH. Management of gout [J]. Jama. 2021;326(24):2519–20. https://doi.org/10.1001/jama.2021.19763
Szeto CC, Sugano K, Wang JG, APAGE/APLAR/APSDE et al. /APSH/APSN/PoA recommendations [J] Gut. 2020;69(4):617–29. https://doi.org/10.1136/gutjnl-2019-319300
McKenzie BJ, Wechalekar MD, Johnston RV et al. Colchicine for acute gout [J]. Cochrane Database Syst Rev. 2021;8(8):Cd006190. https://doi.org/10.1002/14651858.CD006190.pub3
Zhang L, An K, Mou X et al. Effect of Urate-lowering therapy on the progression of kidney function in patients with asymptomatic hyperuricemia: a systematic review and Meta-analysis [J]. Front Pharmacol. 2021;12:795082. https://doi.org/10.3389/fphar.2021.795082
Joosten LAB, Crişan TO, Bjornstad P et al. Asymptomatic hyperuricaemia: a silent activator of the innate immune system [J]. Nat Rev Rheumatol. 2020;16(2):75–86. https://doi.org/10.1038/s41584-019-0334-3
Yip K, Cohen RE, Pillinger MH. Asymptomatic hyperuricemia: is it really asymptomatic? [J]. Curr Opin Rheumatol. 2020;32(1):71–9. https://doi.org/10.1097/bor.0000000000000679
Sellmayr M, Hernandez Petzsche MR, Ma Q et al. Only Hyperuricemia with Crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease [J]. J Am Soc Nephrol. 2020;31(12):2773–92. https://doi.org/10.1681/asn.2020040523
Birben B, Akkurt G, Tez M et al. Long-term impact of sleeve gastrectomy on serum uric acid levels [J]. Turk J Med Sci. 2023;53(1):206–10. https://doi.org/10.55730/1300-0144.5574
Xu C, Wen J, Yang H et al. Factors influencing early serum uric acid fluctuation after bariatric surgery in patients with hyperuricemia [J]. Obes Surg. 2021;31(10):4356–62. https://doi.org/10.1007/s11695-021-05579-4
Luo M, Luo P, Zhang Z et al. Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation [J]. Obesity (Silver Spring). 2016;24(6):1244–56. https://doi.org/10.1002/oby.21463
Cc Wang S, Zhu J, Liu, et al. Chinese Expert Consensus on Precision obesity metabolic surgery (2022 Edition) [J]. ZHONGHUAWEICHANGWAIKEZAZHI. 2022;25(10):841–51. https://doi.org/10.3760/cma.j.cn441530-20220717-00315
doi: 10.3760/cma.j.cn441530-20220717-00315
Marwah RK. Comorbidities in gouty arthritis [J]. J Investig Med. 2011;59(8):1211–20. https://doi.org/10.2130/JIM.0b013e318239f660
doi: 10.2130/JIM.0b013e318239f660
pubmed: 22064605
Schiavo L, Favrè G, Pilone V et al. Low-purine Diet is more effective Than Normal-Purine Diet in reducing the risk of gouty attacks after sleeve gastrectomy in patients suffering of gout before surgery: a retrospective study [J]. Obes Surg. 2018;28(5):1263–70. https://doi.org/10.1007/s11695-017-2984-z
Tana C, Busetto L, Di Vincenzo A et al. Management of hyperuricemia and gout in obese patients undergoing bariatric surgery [J]. Postgrad Med. 2018;130(6):523–35. https://doi.org/10.1080/00325481.2018.1485444
Song K, He M, Kong X et al. Benefits of uric acid-lowering medication after bariatric surgery in patients with gout [J]. BMC Surg. 2024;24(1):186. https://doi.org/10.1186/s12893-024-02472-6
Oldmeadow LB, Edwards ER, Kimmel LA et al. No rest for the wounded: early ambulation after hip surgery accelerates recovery [J]. ANZ J Surg. 2006;76(7):607–11. https://doi.org/10.1111/j.1445-2197.2006.03786.x
Siu AL, Penrod JD, Boockvar KS et al. Early ambulation after hip fracture: effects on function and mortality [J]. Arch Intern Med. 2006;166(7):766–71. https://doi.org/10.1001/archinte.166.7.766
Richette P, Poitou C, Garnero P et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis [J]. Ann Rheum Dis. 2011;70(1):139–44. https://doi.org/10.1136/ard.2010.134015
Dessein PH, Shipton EA, Stanwix AE et al. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study [J]. Ann Rheum Dis. 2000;59(7):539–43. https://doi.org/10.1136/ard.59.7.539
ZoomForward2022. European Congress on Obesity [J]. Obes Facts. 2022;15 Suppl 1:1-240. https://doi.org/10.1159/000524469
Eisenberg D, Shikora SA, Aarts E et al. 2022 American Society for Metabolic and bariatric surgery (ASMBS) and International Federation for the Surgery of Obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery [J]. Surg Obes Relat Dis. 2022;18(12):1345–56. https://doi.org/10.1016/j.soard.2022.08.013
Bal BS, Finelli FC, Shope TR et al. Nutritional deficiencies after bariatric surgery [J]. Nat Rev Endocrinol. 2012;8(9):544–56. https://doi.org/10.1038/nrendo.2012.48
Bettini S, Belligoli A, Fabris R et al. Diet approach before and after bariatric surgery [J]. Rev Endocr Metab Disord. 2020;21(3):297–306. https://doi.org/10.1007/s11154-020-09571-8
Wang W, Liou TH, Lee WJ et al. ESR1 gene and insulin resistance remission are associated with serum uric acid decline for severely obese patients undergoing bariatric surgery [J]. Surg Obes Relat Dis. 2014;10(1):14–22. https://doi.org/10.1016/j.soard.2012.10.011
Hartmaier RJ, Trabucco SE, Priedigkeit N et al. Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer [J]. Ann Oncol. 2018;29(4):872–80. https://doi.org/10.1093/annonc/mdy025
Yang W, Jiang W, Liao W et al. An estrogen receptor α-derived peptide improves glucose homeostasis during obesity [J]. Nat Commun. 2024;15(1):3410. https://doi.org/10.1038/s41467-024-47687-6
Arterburn DE, Telem DA, Kushner RF et al. Benefits and risks of bariatric surgery in adults: a review [J]. Jama. 2020;324(9):879–87. https://doi.org/10.1001/jama.2020.12567